News – Page 95 – Endpoints News

Sen. Cassidy questions Lilly and Amgen on 340B restrictions on contract pharmacies

7 months ago

Corrected: Over a year after FDA rejection, Biohaven claims success in pivotal neurodegenerative disease study

7 months ago

UCB adds three more FDA approvals to label for potential blockbuster Bimzelx

7 months ago

Context makes a T cell engager deal; Ginkgo Bioworks backers have a new SPAC

7 months ago

Black Diamond treads water on small snapshot of Phase 2 lung cancer data

7 months ago

Q&A: Bristol Myers’ tech chief on the promises and perils of AI bio

7 months ago

Is Sanofi making a move into obesity? French pharma invests $27M into Ventyx

7 months ago

Telix buys radiopharmacy network for $230M up front to expand US capacity

7 months ago

Ideaya outlines regulatory path for rare eye cancer drug after positive mid-stage data

7 months ago

AstraZeneca, Daiichi’s TROP2 drug misses overall survival goal in Phase 3 breast cancer trial

7 months ago

UK vaccine startup Vicebio snags $100M to take on GSK, Pfizer and Moderna

7 months ago

John Carroll on his cancer diagnosis; #ESMO's biggest surprise; Lykos' bad trip; Rate cuts, and more

7 months ago

Regulatory RNA startup CAMP4 files for IPO as more biotechs line up listings

7 months ago

A VC-backed genetic testing startup to 'consider' making an offer to buy 23andMe

7 months ago

Sanofi's Sarclisa gets approved as a first-line option for some patients newly diagnosed with multiple myeloma

7 months ago

The drug lobby's lawsuit against the IRA finds a sign of life after appeals court ruling

7 months ago

Why did Eli Lilly ask a patient on a compounded GLP-1 drug for their medical information?

7 months ago

J&J will defend its proposed 340B changes as US threatens penalties

7 months ago

FDA OKs the first-ever self-administered vaccine, for flu

7 months ago

European regulators reaffirm Apellis’ rejection, add eight positive recommendations

7 months ago

FTC to sue major PBMs over insulin rebates, claiming they inflated patient cost

7 months ago

Yuhan ends cancer project with J&J as it signs API deal with Gilead on HIV drugs

7 months ago

Updated: FDA approves Zevra’s rare disease drug after resubmission

7 months ago

Biotech VC firm outlines plans for $100M fund

7 months ago

First page Previous page 92 93 949596 97 98 Next page Last page